LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$89.96 USD
-0.22 (-0.24%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $89.90 -0.06 (-0.07%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
LMAT 89.96 -0.22(-0.24%)
Will LMAT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LMAT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LMAT
Molina Healthcare Stock Rises 15.4% in 3 Months: Should You Buy?
Smart Investors Are Holding Acadia Healthcare Stock Now: Here's Why
LMAT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Universal Health Shares are Attracting Investors Now
Select Medical Agrees to Acquire Valir Rehabilitation Hospital
Centene Stock Rises 29% in a Year: Evaluating the Road Ahead
Other News for LMAT
BCE Is Dead To Me - August Dividend Income Report
Conestoga Capital Advisors Q2 2024 Commentary
LeMaitre to Participate at Upcoming Investor Conferences in September
Lemaitre Vascular (LMAT) Gets a Buy from Lake Street
LeMaitre Vascular CFO Retires, Joins Board of Directors